Skip to main content

Table 1 Patient characteristics by age group

From: Confirmatory validation of the french version of the Duchenne Muscular Dystrophy module of the pediatric quality of life inventory (PedsQLTM3.0DMDfv)

 

Age group

 

4–7 yrs

8–11 yrs

12–18 yrs

Total

(N = 16)

(N = 53)

(N = 38)

(N = 107)

Variable

n(%)

n(%)

n(%)

n(%)

Clinical diagnosis

 Deletion

11 (84.6)

31 (62.0)

24 (64.9)

66 (66.0)

 Duplication

1 (7.7)

8 (16.0)

3 (8.1)

12 (12.0)

 Point mutation

1 (7.7)

11 (22.0)

10 (27.0)

22 (22.0)

Walking ability acquired

 No

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

 Yes

15 (100.0)

53 (100.0)

38 (100.0)

106 (100.0)

 N missing

1

0

0

 

Loss of walking ability

 No

15 (100.0)

24 (46.2)

0 (0.0)

39 (37.1)

 Yes

0 (0.0)

28 (53.8)

38 (100.0)

66 (62.9)

 N missing

1

1

0

 

Severity: not walking and ventilated

 No

16 (100.0)

50 (94.3)

29 (76.3)

95 (88.8)

 Yes

0 (0.0)

3 (5.7)

9 (23.7)

12 (11.2)

 N missing

0

0

0

 

Medication treatment: corticosteroids

 No

8 (57.1)

10 (20.0)

25 (65.8)

43 (42.2)

 Yes

6 (42.9)

40 (80.0)

13 (34.2)

59 (57.8)

 N missing

2

3

0